Keywords:Angiomax, bivalirudin Trifluoroacetate, bivalirudina

Product nomen:Bivalirudin

CasNo:128270-60-0

Formulae hypotheticae:C98H138N24O33

Pondus hypotheticum:2180.3g/mol

Aspectus:cerussa

Applicatio:Curatio generis 2 diabete

Sarcina:Secundum Lorem scriptor requisitis

De JYMed.

Shenzhen JYMed Technologia Co, Ltd. (infra postea ad JYMed) anno 2009 confirmata est, specialiter in investigatione, progressione, productione et venditio peptidum et productorum peptilium relatarum. Uno centro investigationis et tribus basium productionibus maioris, JYMed est unus e maximis effectoribus peptidis chemici APIs in Sinis. Societates nucleus R&D globus super XX annos experientiae in industria peptida gloriatur et inspectiones bis FDA feliciter transegit. JYMed ratio comprehensiva et efficiens peptida industrialis ratio clientibus plenam amplitudinem officiorum praebet, incluso evolutione et productione peptidum therapeuticorum, peptidum veterinarii, peptidum antimicrobiale, et peptidum medicamen, necnon adnotationes et subsidia moderantia.

Principalis Negotia Operationes

1.Domestic et internationalis adnotatione peptide APIs

2.Veterinary et medicamine peptides

3. Consuetudo peptides et CRO, CMO, OEM officia

4.PDC medicamenta (peptide-radionuclides, peptide-molecula parva, interdum peptide, peptide-rna)

Contact Us

Shenzhen JYMed Technology Co., Ltd.

Oratio:8th & 9th Floors, Aedificium 1, Shenzhen Biomedica Innovatio Industrialis Park, No. 14 Jinhui Road, Kengzi Subdistrict, Pingshan Districtus, Shenzhen

Phone:+86 755-26612112

Website:http://www.jymedtech.com/